Lung Diseases


What is Bronchiectasis?

Bronchiectasis is a pulmonary condition in which damage to the airways causes them to widen and become scarred. The lung disease causes your airways to slowly lose their ability to clear out mucus. As a result, the mucus continues to build up creating a mucus blockage, which allows bacteria to continually grow. This often results in repeated lung infections. The blockage and accompanying infections cause inflammation, which lead to weakened air passages and difficulty breathing. Over time, the airways will lose their ability to move air in and out. This can prevent a sufficient amount of oxygen from reaching vital life-sustaining organs.

Bronchiectasis can develop at any age. The onset of the condition typically can predict the type and cause of the disease. There are two very distinct types of bronchiectasis: congenital and non-congenital (also known as acquired).

Non-Congenital Bronchiectasis

Non-congenital bronchiectasis develops after birth. It is typically the result of an injury to a sufferer’s airway walls or another disease such as tuberculosis, pneumonia or influenza. In rare cases, the condition develops because of a growth or foreign object in the airway. Some conditions result from an object you inhaled as a child such as a piece of a toy or peanut. Non-congenital bronchiectasis typically leads to the development of related lung disease symptoms which can be effectively treated with stem cell therapy at the Lung Institute. After treatment, patients report being able to breathe easier once again.

Congenital Bronchiectasis

Congenital bronchiectasis usually occurs as part of a birth defect—such as primary ciliary dyskinesia or cystic fibrosis. It can also result from defects in lung development while a fetus. Congenital bronchiectasis also typically leads to the development of related lung disease symptoms which can be effectively treated with stem cell therapy at the Lung Institute.

The symptoms of non-congenital bronchiectasis can differ from person to person. Most commonly, sufferers will experience the following:

  • Coughing (typically worsens when laying down)
  • Shortness of Breath
  • Abnormal Chest Sounds
  • Daily Production of Large Amounts of Coughed Up Mucus
  • Chest Pain
  • Clubbing (flesh under fingernails and toenails becomes thicker)


Bronchiectasis is a disease that doesn’t discriminate. Both women and men can develop bronchiectasis, but women have a higher risk of development. Overall, two-thirds of individuals with bronchiectasis are women.


Non-congenital bronchiectasis typically affects adults and older children. It is significantly more common than the congenital type, which only affects children.

If you would like to find out more about our available treatment options, please contact one of our patient care coordinators today at (800) 729-3065 to schedule a free consultation.

Related Posts

  • How Do Researchers Feel About Stem Cell Therapy? A Look at the FieldThe decision to pursue stem cell therapy can be a challenging decision to make. Sometimes, you need to hear something from someone behind the microscope. So, with your health in ... Read more
  • Cleaner Air in 5 Easy StepsHaving clean air is important, especially when you live with chronic lung disease. Keep reading to learn 5 easy steps for having cleaner air here. Read more

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.